Gene Query: LARP1B

Dataset Description Geneva Score
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 61.69
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 38.87
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 31.95
Gene expression analysis of dengue-infected cells 25.1
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 24.16
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 18.89
RNA sequencing of matched nephrectomy samples [RNA-seq] 18.89
R430: A potent inbibitor of DNA and RNA viruses 18.3
Gene expression in PANC1 cells treated with Rakicidin 17.05
Oncogenic MYC induces a dependency on the spliceosome in human cancer 15.9
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 15.31
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 14.92
Recovery and analysis of nascent RNA 14.92
The Human Testis Cell Atlas via Single-cell RNA-seq 14.8
RNA-sequencing of human liver tissue 14.54
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 13.86
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 13.86
In vitro modeling of human germ cell development using pluripotent stem cells 13.69
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 13.52
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 13.21
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 13.11
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 12.29
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 12.02
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 11.95
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 11.86
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 11.19
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.11
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.11
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 10.9
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 10.9
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 10.82
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 10.74
Short and Long RNA sequencing of human mature erythrocytes 10.62
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 10.51
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 10.49
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 9.89
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 9.81
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 9.75
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 9.55
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 9.32
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.22
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 9.09
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 8.96
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.63
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 8.6
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 8.3
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 8.27
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 8.14
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 8.04
Tracking distinct RNA populations using efficient and reversible covalent chemistry 7.97
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 7.91
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 7.91
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 7.84
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.81
RNA-Seq from early time points in the kidney differentiation protocol 7.81
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 7.79
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 7.52
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 7.47
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 7.47
Global Mapping of Human RNA-RNA Interactions 7.23
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 7.15
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.15
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.08
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.87
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.67
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 6.66
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.62
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.52
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.44
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.41
Human cell line and subcutaneous tumor 6.37
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 6.36
The MEF2B Regulatory Network - RNA-seq data 6.33
The MEF2B Regulatory Network 6.33
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.31
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 6.23
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 6.18
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.12
RNA sequencing of primary human platelets and in vitro cell lines 6.08
The conserved transcriptional landscapes in human spermatogenesis 6.08
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 6.01
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 5.98
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 5.88
The cohesin release factor WAPL restricts chromatin loop extension. 5.88
Dtx3L and Androgen Signaling in Prostate Cancer 5.82
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 5.77
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 5.77
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.77
Tracking of dCas9-methyltransferase footprints 5.76
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 5.75
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 5.73
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 5.68
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 5.67
Region-specific Innate Antiviral Responses of the Human Epididymis 5.63
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.52
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 5.46
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 5.46
Cajal bodies are linked to genome conformation 5.37
Cajal bodies are linked to genome conformation [RNA-Seq] 5.37
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.32
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.29
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 5.27
Genome-wide analysis of Dengue virus 2 infected cells 5.27
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.26
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.26
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.22
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 5.19
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 5.19
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.18
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 5.14
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 5.14
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 5.14
Loss of CREBBP results in gene expression repression in lymphoma cells 5.1
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.1
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 5.09
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.06
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 5.04
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 5.0
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.96
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.96
AR-independent prostate cancer is sustained through FGF signaling 4.9
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.89
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 4.87
IRF2 is a master regulator of human keratinocyte stem cell fate 4.87
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 4.87
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 4.86
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.8
Gene expression analysis of human hepatocellular cancers 4.79
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.77
FBXW7 modulates stress response by post-translational modification of HSF1 4.77
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 4.76
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 4.76
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.74
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 4.66
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 4.66
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.6
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.6
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 4.56
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 4.55
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 4.54
Transcriptome analysis of H9 hESC derived cerebral organoids 4.53
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.51
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.5
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 4.49
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.48
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 4.48
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.44
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.44
Effect of PRDM11 depletion in U2932 cells 4.43
Changes in human endometrial gland transcriptome over the window of implantation 4.4
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 4.35
Exploring ILF2 regulatory genes by next-generation sequencing 4.35
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.32
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 4.32
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.28
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.28
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.25
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.24
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.24
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 4.22
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 4.21
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.18
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 4.18
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.12
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.08
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 4.08
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 4.05
Role of CD133 molecule in WNT response and renal repair 4.05
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 4.04
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 4.02
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.01
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.98
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.98
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 3.98
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 3.94
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 3.94
RNAseq Analysis in glioblastoma cells treated with Mepazine 3.94
Identification of global XBP1s target gene expression in human prostate cancer cells 3.93
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 3.92
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.92
EP400 is required for Max and MCPyV mediated gene activation 3.9
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.9
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 3.89
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 3.87
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 3.86
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.86
Neonatal and adult human testis defined at the single-cell level 3.83
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 3.79
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.79
RNA Seq of HMVEC under hypoxia 3.79
Zika infected neural stem cells 3.79
Transcriptome analysis of Zika infected neural stem cells 3.79
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 3.78
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.77
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.76
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 3.76
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.73
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.72
Cerebellar differentiation in Ataxia-Telangiectasia 3.72
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 3.71
Knockdown of ADNP in HCT116 colon cancer cells 3.69
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 3.68
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 3.65
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.62
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 3.6
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 3.6
RNA sequencing analysis of selumetinib-resistant CRC cells lines 3.6
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 3.59
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 3.58
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.58
A map of gene expression in neutrophil-like cell lines 3.57
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.56
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 3.56
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 3.56
circNFIB suppresses lymphatic metastasis of pancreatic cancer 3.54
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.53
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 3.52
IDH3a KO RNA-seq 3.52
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.49
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 3.49
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.47
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.45
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 3.41
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 3.38
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 3.38
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.32
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.31
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 3.3
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.29
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 3.28
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.27
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.26
Primary human trophoblast from term placenta 3.25
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.24
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.24
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 3.22
Transcriptome analysis in Neobractatin treated cells 3.22
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.2
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.19
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.16
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.16
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 3.15
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.14
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.14
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.09
SLIGRL-induced gene expression changes in NHEK cells 3.08
ARID1A and ARID1B loss in HCT116 cells 3.06
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.06
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.06
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.06
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.98
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.96
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.96
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.96
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 2.94
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.94
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.93
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.92
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.92
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 2.92
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.92
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.91
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.91
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.91
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.9
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.89
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 2.88
Landscape of H3K4me3 in human CD19 cells 2.88
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 2.87
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.86
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.86
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 2.86
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 2.83
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 2.82
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 2.8
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.79
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 2.78
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 2.78
Single-cell analysis of human kidney organoids 2.78
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.76
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 2.75
Identification of a LIF-responsive replication-competent human β cell 2.73
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 2.73
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.73
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 2.72
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.69
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.65
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 2.64
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.58
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.56
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 2.55
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 2.55
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.55
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.54
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.54
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.51
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.5
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.5
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 2.45
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 2.45
Regulation of hypoxia-inducible factor activity by ZMYND8 2.44
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 2.44
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.43
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.43
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.4
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 2.4
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 2.39
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.38
A single cell reference map for human blood and tissue T cell activation 2.36
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.35
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.34
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.31
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.31
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.24
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.23
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 2.17
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 2.17
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 2.17
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.16
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.14
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.14
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.13
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.12
LIN28A Over-expression RNAseq 2.1
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 2.04
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 1.97
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.95
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.93
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.93
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.92
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.92
AMPK signaling for naïve pluripotency [Hs] 1.9
AMPK signaling for naïve pluripotency 1.9
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 1.9
Deep RNA sequencing of the human placental transcriptome 1.9
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.89
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.89
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.89
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.88
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.87
The contribution of Alu exons to the human proteome 1.86
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.86
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.84
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.84
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.81
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.81
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.8
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.8
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 1.77
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.75
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.75
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.75
The transcriptome and chromatin accessbility landscape of mammalian germline 1.73
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.72
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 1.71
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 1.7
JunB control of keratinocyte-mediated inflammation [RNA-seq] 1.64
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 1.64
Global response to chemotherapy-induced apoptosis 1.64
High-resolution comparative analysis of great ape genomes 1.63
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.59
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.54
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.54
Transcriptome analysis of SKI knock-out in HL60 cells 1.54
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.53
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.52
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.52
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.51
Next Generation Sequencing of human SMA and healthy control Motor Neurons 1.49
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.48
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.46
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.46
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.46
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.45
RNA-Seq of PRMT1 overexpression ECA109 cells 1.45
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.44
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.44
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.44
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.42
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.41
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.37
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 1.36
Genome-wide analysis of the Integrator complex (HTS) 1.3
Genome-wide analysis of the Integrator complex 1.3
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.29
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 1.29
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 1.28
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.26
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.26
Transcriptional landscape changes during human embryonic stem cell derivation 1.26
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.25
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.25
Human islets of varying quality: the good, the (not so) bad and the ugly 1.24
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.23
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.23
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.23
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.23
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.23
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.22
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.2
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.19
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.15
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.15
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.14
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.13
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.13
Functional significance of the HIV-1 Tat signature amino acid residues 1.1
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.1
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.1
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.07
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.07
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.06
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.04
SLAM-seq for K562 endogenous mRNA decay 1.04
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.03
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.01
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.01
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.99
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.98
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.98
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.92
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.91
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.91
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 0.91
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.88
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.86
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.83
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.8
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.75
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.75
Leucegene: AML sequencing (part 6) 0.73
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.72
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.72
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.71
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.71
SNHG5 siRNA knock down in HCT116 cells 0.7
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.69
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.69
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.69
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.66
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.64
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.63
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.62
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.61
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.61
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.58
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.57
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.56
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.56
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 0.55
The cytokine environment influence on human skin-derived T cells 0.53
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.51
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.46
Modulation of nonsense-mediated decay by rapamycin 0.45
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.45
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.44
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.42
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.38
Activity-dependent transcriptional changes in human neurons 0.37
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.36
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.33
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.33
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.32
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.3
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.3
The role of CFTR in islet function 0.25
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.25
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.25
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.2
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.19
Preclinical model of obesity and ER-positive breast cancer 0.17
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.14
Human Treg IFNg/IL-10 subpopulations 0.14
IMP3 regulated gene expression in breast cancer cells 0.12
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.12
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.11
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.1
Metastasis in triple-negative breast cancer 0.1
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.1
Iron response of HepG2 cells 0.09
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.08
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.08
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.08
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.08
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.08
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.04
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.04
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.04
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.03
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.03
RNAseq analysis of ruxolitinib treated breast cancers 0.03
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.03
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.02
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.01
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.0
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation